News
CYTH
0.6300
+1.61%
0.0100
Weekly Report: what happened at CYTH last week (1209-1213)?
Weekly Report · 6d ago
RAFAEL HOLDINGS REPORTS FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS
Reuters · 12/11 12:00
Weekly Report: what happened at CYTH last week (1202-1206)?
Weekly Report · 12/09 12:02
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 12/04 21:06
Weekly Report: what happened at CYTH last week (1125-1129)?
Weekly Report · 12/02 12:02
Weekly Report: what happened at CYTH last week (1118-1122)?
Weekly Report · 11/25 11:51
Weekly Report: what happened at CYTH last week (1111-1115)?
Weekly Report · 11/18 11:48
Based on the provided financial report article, the title of the article is likely: "CTDH 2024 Q3 10-Q Filing: Thunderdome, Inc. Reports Financial Results for the Quarter Ended September 30, 2024" Note that the title may vary depending on the specific content and context of the article.
Press release · 11/14 23:04
Cyclo Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Reuters · 11/14 20:55
Cyclo Therapeutics reports Q3 results
Seeking Alpha · 11/14 20:29
Cyclo Therapeutics Q3 EPS $(0.31) Misses $(0.16) Estimate, Sales $233.77K Miss $294.00K Estimate
Benzinga · 11/14 13:38
*Cyclo Therapeutics: Ended 3Q With About $900,000 of Cash >CYTH
Dow Jones · 11/14 13:07
*Cyclo Therapeutics 3Q R&D Expenses Rose 57% to $5.5M >CYTH
Dow Jones · 11/14 13:07
*Cyclo Therapeutics: On Track for Topline Data From the 48-Week Interim Analysis of 104 Enrolled Patients in TransportNPC in 1H 2025 >CYTH
Dow Jones · 11/14 13:07
Cyclo Therapeutics, Inc. (CYTH) Reports Q3 Loss, Lags Revenue Estimates
NASDAQ · 11/14 12:20
Weekly Report: what happened at CYTH last week (1104-1108)?
Weekly Report · 11/11 12:05
IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 11/08 13:00
CYCLO THERAPEUTICS : NOTE MATURES ON DECEMBER 21
Reuters · 11/08 11:07
CYCLO THERAPEUTICS: UNDER AGREEMENT, ISSUED & SOLD CONVERTIBLE PROMISSORY NOTE IN AMOUNT OF $2 MLN TO RAFAEL HOLDINGS
Reuters · 11/08 11:07
RAFAEL HOLDINGS REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2024 FINANCIAL RESULTS
Reuters · 11/07 00:14
More
Webull provides a variety of real-time CYTH stock news. You can receive the latest news about Cyclo Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYTH
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company’s Trappsol Cyclo, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C1, a rare and fatal genetic disease, (NCT02939547, NCT02912793, NCT03893071 and NCT04860960). The Company is also engaged in conducting a Phase 2b clinical trial using Trappsol Cyclo intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842).